Mind'sEye Diagnostics

Company Overview

Snapshot

Founded in January 2017 by Ophir Atar, Mind'sEye Diagnostics operated with 1–10 employees. The company raised $700K across one funding round from one investor. In December 2017, the company secured Seed funding from eHealth Ventures.

Business overview

Mind'sEye Diagnostics developed a mobile platform for the diagnosis and monitoring of ADHD using eye biomarkers. The system identifies eye patterns associated with ADHD, providing an attention score to aid in diagnosis and manage medication or activities affecting attention. The Mind'sEye app utilizes a phone's camera to scan the user's eye, determining factors influencing attention levels and recommending specific foods or physical activities to improve focus. The company operated within the Health Tech & Life Sciences sector, focusing on digital healthcare, medical devices, and diagnostics for patients.

Company Intelligence Q&A

What is Mind'sEye Diagnostics' primary focus?

Mind'sEye Diagnostics focuses on developing a mobile platform for ADHD diagnosis and monitoring based on eye biomarkers, identifying unique eye patterns to provide an attention score.

When was Mind'sEye Diagnostics founded?

Mind'sEye Diagnostics was founded in January 2017.

Who founded Mind'sEye Diagnostics?

Mind'sEye Diagnostics was founded by Ophir Atar.

What was the company's operational status?

Mind'sEye Diagnostics ceased to operate in November 2022.

What was the total capital raised by Mind'sEye Diagnostics?

Mind'sEye Diagnostics raised a total of $700K across one funding round.